Advacan 0.5mg Tablet

Advacan 0.5mg tablet is an antineoplastic drug in the mTOR kinase inhibitor class. It contains everolimus as the active ingredient. It is indicated for treatment of advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and subependymal giant cell astrocytoma (tumours found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during treatment as this medicine can cause oral sores or ulcers. For subependymal giant cell astrocytoma, it is often used in combination with cyclophosphamide, an alkylating agent.

Before taking Advacan 0.5mg tablet, understand that risk of bacterial or viral infection increases during this treatment. If you have hepatitis B infection, Advacan 0.5mg tablet increases the risk of reinfection. Inform your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during treatment.

Limit exposure to sunlight and UV light by wearing protective clothing and applying sunscreen regularly, as Advacan 0.5mg tablet may increase the risk of developing cancers. Avoid grapefruit juice and grapefruit while taking this medicine.

Advacan tablet is not recommended for adolescents and children under 18 years of age. Contact your doctor immediately if you develop shortness of breath, chest pain, or worsening cough.

During Advacan 0.5mg tablet treatment, your doctor may periodically monitor white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. Advacan 0.5mg tablet has the potential to cause kidney problems. Inform your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting treatment.

Avoid live vaccines and close contact with persons who have received live vaccines.

The Advacan 0.5mg Tablet is used in the treatment of the following: Advanced breast cancer Advanced renal cell carcinoma Advanced pancreatic neuroendocrine tumours Treatment of subependymal giant cell astrocytoma

Advacan 0.5mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumours and improve outcomes in patients.

Take the Advacan tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious side effects of Advacan 0.5mg Tablet are: Difficulty breathing or swallowing Swelling of face, lips, tongue, throat Severe itching, red rash, raised bumps Common side effects of Advacan 0.5mg Tablet are: Infection (chills, increased temperature) Coughing Wheezing Excessive thirst High urine output or severely decreased urine output Tiredness Bleeding Increased appetite with weight loss

Advacan 0.5mg tablets have the tendency to cause harm to the unborn foetus. Inform your healthcare provider before starting this treatment if you are pregnant, or planning for pregnancy. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug. Discuss effective birth control methods with your healthcare provider and use them during the treatment for 8 weeks after your last dose. This medicine passes into breast milk. Hence, it is not recommended to breastfeed during this treatment. The occurrence of mouth ulcers or sores is pretty common during this treatment, so your healthcare provider will prescribe a mouthwash. Use the mouthwash as recommended, which helps prevent and manage the symptoms.